Future of Novel Therapies in the Management of Relapsed and Refractory Multiple Myeloma
Dana-Farber Cancer Institute via YouTube
Master Production-Ready Machine Learning, Step by Step
Stuck in Tutorial Hell? Learn Backend Dev the Right Way
Overview
Build a Learning Habit
Download Class Central's free printable study calendar
Download for Free
In this 26-minute video, Dr. Paul Richardson from Dana-Farber Cancer Institute offers a clinical perspective on emerging treatment approaches for patients with relapsed/refractory multiple myeloma. Gain insights into innovative therapies that show promise for improving outcomes in this challenging disease setting. Explore the evolving landscape of multiple myeloma management, including new drug combinations, immunotherapies, and targeted approaches that are reshaping treatment paradigms for patients who have experienced disease progression after initial therapy.
Syllabus
Future of Novel Therapies in the Management of Relapsed and Refractory Multiple Myeloma
Taught by
Dana-Farber Cancer Institute